Enhancement of sialylation on humanized IgG-like bispecific antibody by overexpression of α2,6-sialyltransferase derived from Chinese hamster ovary cells
Abstract
Improvement of glycosylation is one of the most important topics in the industrial production of therapeutic antibodies. We have focused on terminal sialylation with alpha-2,6 linkage, which is crucial for anti-inflammatory activity. In the present study, we have successfully cloned cDNA of beta-galactosyl alpha-2,6 sialyltransferase (ST6Gal I) derived from Chinese hamster ovary (CHO) cells regardless of reports that stated this was not endogenously expressed in CHO cells. After expressing cloned ST6Gal I in Escherichia coli, the transferase activity was confirmed by HPLC and lectin binding assay. Then, we applied ST6Gal I to alpha-2,6 sialylation of the recombinant antibody; the ST6Gal I expression vector was transfected into the CHO cell line producing a bispecific antibody. The N-glycosylation pattern of the antibody was estimated by HPLC and sialidase digestion. About 70% of the total N-linked oligosaccharide was alpha-2,6 sialylated in the transfected cell line whereas no sialylation was observed in the non-transfected cell line. The improvement of sialylation would be of practical importance for the industrial production of therapeutic antibodies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Transient transfection of the Chinese hamster ST6Gal1 gene in CHO cells expressing a bispecific antibody also considerably increased the level of α2,6 sialylation.
“Finally, transient transfection of the Chinese hamster ST6Gal1 gene in CHO cells expressing a bispecific antibody, also considerably increased the level of α2,6 sialylation (Onitsuka et al., 2012).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Onitsuka et al., 2012
Cites
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · see citing works
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413 · see citing works
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296 · see citing works
Production of α2,6-sialylated IgG1 in CHO cells
Raymond, C., Robotham, A., Spearman, M., Butler, M., Kelly, J., & Durocher, Y. (2015) · mAbs · doi:10.1080/19420862.2015.1029215 · Cited by 106 · see citing works
Antibody glycoengineering strategies in mammalian cells
Wang, Q., Chung, C., Chough, S., & Betenbaugh, M. J. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26567 · Cited by 94 · see citing works
Production of Highly Sialylated Monoclonal Antibodies
(2012) · InTech eBooks · doi:10.5772/51301 · Cited by 20 · see citing works
- Authors
- Onitsuka, M., Kim, W.-D., Ozaki, H., Kawaguchi, A., Honda, K., Kajiura, H., Fujiyama, K., Asano, R., Kumagai, I., Ohtake, H., & Omasa, T.
- Affiliations
- Tokushima University (JP)
- The University of Osaka (JP)
- International Center for Biotechnology, The University of Osaka (JP)
- Tohoku University (JP)
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2011-12-29
- Volume
- 94
- Issue
- 1
- Pages
- 69-80
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- OpenAlex
- W1990345672
- Cited by
- 48
- References
- 3
- Citations by year
- 2026: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 3 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 3 · 2013: 9 · 2012: 2
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Applied Microbiology and Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut national de la recherche scientifique
- National Institute of Biomedical Innovation
- Japan Society for the Promotion of Science (23360371, 23686118)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Keywords
- alpha-2,6-sialyltransferase, ST6Gal I, bispecific antibodies, antibody glycosylation, N-glycans, CHO cell transfection, recombinant antibody production, anti-inflammatory activity, Escherichia coli expression
- MeSH terms
- beta-D-Galactoside alpha 2-6-Sialyltransferase, Animals, Escherichia coli, Female, Cricetinae, Humans, Immunoglobulin G, Ovary, Recombinant Proteins, Sialyltransferases, Up-Regulation, Gene Expression, CHO Cells, Antibodies, Bispecific, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review